iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
10.13
+0.03 (0.30%)
At close: Aug 13, 2025, 4:00 PM
10.12
-0.01 (-0.10%)
After-hours: Aug 13, 2025, 4:35 PM EDT
iTeos Therapeutics Market Cap
iTeos Therapeutics has a market cap or net worth of $447.80 million as of August 13, 2025. Its market cap has decreased by -30.70% in one year.
Market Cap
447.80M
Enterprise Value
-62.94M
1-Year Change
-30.70%
Ranking
Category
Stock Price
$10.13
Market Cap Chart
Since July 24, 2020, iTeos Therapeutics's market cap has decreased from $636.93M to $447.80M, a decrease of -29.69%. That is a compound annual growth rate of -6.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 447.36M | 59.44% |
| Dec 31, 2024 | 280.58M | -28.40% |
| Dec 29, 2023 | 391.85M | -43.60% |
| Dec 30, 2022 | 694.79M | -57.70% |
| Dec 31, 2021 | 1.64B | 38.57% |
| Dec 31, 2020 | 1.19B | 86.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 590.49B |
| Johnson & Johnson | 419.05B |
| AbbVie | 354.35B |
| UnitedHealth Group | 245.21B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.02B |
| Novo Nordisk | 223.00B |